Fixed 400-Microgram Dose Removes Need for Weight-Based Calculation No Infusion Pump Required, Simplifying the Procedure Launch Planned for February-March Next Year Without Insurance Coverage GE HealthCare will launch Rapiscan (regadenoson), a selective adenosine A2A receptor agonist, in South Korea in February…
Using an AI tool to measure left-ventricular ejection fraction on cardiac magnetic resonance imaging (CMR) marginally outperforms clinician measurement for the prediction of all-cause mortality, supporting the use of AI as a first-line approach with clinician oversight in this setting.
An artificial intelligence tool that analyzed round-the-clock readings from a portable blood pressure cuff and a wrist-worn tracker identified patients at higher risk of a hypertensive crisis up to 72 hours in advance, according to preliminary research released by the American…
TVB Medical Council member steps down over young girl coroner inquest case Alex Lam, a Medical Council member elected by patient organisations and pro bono lawyer for the Coroner's Inquest into the medical incident involving the young girl Chau Tin-yu,…
Posted by Kim Johansen on Nov 4th, 2026 Several brokerages have updated their recommendations and price targets on shares of DexCom (NASDAQ: DXCM) in the last few weeks: DexCom, Inc develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes. Its…
The Endocrine and Metabolism Society of Nigeria has raised concerns over the shortage and uneven distribution of endocrinologists in the country, warning that the high cost of essential medicines, insulin and modern diabetes treatment technologies is further limiting access to…
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan. According to Brooke Hudspeth, PharmD, associate dean of pharmacy practice at the University of Kentucky College of Pharmacy, the overall…
Presented by Managed Healthcare Executive and Drug Topics In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than those using finger-stick testing. Continuous glucose monitoring led to larger A1C reductions…
October 26, 2026 By Conor Hale The first-in-human trial of its Freedom system will evaluate a one-year, under-the-skin sensor that links directly with the user’s smartphone, doing away with the need for additional on-body hardware and making a CGM as discreet as…
HSSIB calls for safer insulin management The availability of diabetes technologies such as continuous glucose monitors (CGMs), insulin pumps, hybrid closed loop (HCL) systems and smart insulin pens remains inconsistent across England, an investigation has found. A report identified concerns…
Heart rate, ECG, SpO₂, HRV, glucose sensors, and adherence tools at home.
An article joins this feed when it matches these terms. Each one is also a search of its own.